[e-drug] New report on AIDS and economics

[e-drug@usa.healthnet.org]

E-drug: New report on AIDS and economics
-------------------------------------------------------------------------

[Copied from Ip-health. The full report is 129 pages. KM]

Report from the POLICY Project, and Merck:

State of the Art: AIDS and Economics
http://www.policyproject.com/pubs/other/SOTAecon.pdf

Section One: The Various Roles of Economics in Addressing the HIV/AIDS
Pandemic (overview)

Chapter 1: Current and Future Resources for HIV/AIDS
William McGreevey, Stefano Bertozzi, Juan-Pablo Gutierrez, Marjorie Opuni,
Jose-Antonio Izazola

Chapter 2: HIV / AIDS and Globalization -- What Is the Epidemic Telling Us
About Economics, Morality, and Pragmatism?
Tony Barnett

Chapter 3: The Economics of Social and Structural Interventions for HIV
Prevention in Developing Countries
Beena Varghese

Section Two: Understanding the Impact of HIV/AIDS (overview)

Chapter 4: HIV / AIDS, Health, and Education
Alan Whiteside

Chapter 5: How Does HIV / AIDS Affect African Business?
Steven Forsythe

Chapter 6: HIV / AIDS and Its Impact on Trade and Commerce
Lori Bollinger

Chapter 7: AIDS and Macroeconomic Impact
Robert Greener

Section Three: Using Economics to Respond to the Pandemic (overview)

Chapter 8: Resource Allocation Within HIV / AIDS Programs
John Stover, Lori Bollinger

Chapter 9: Cost-Effectiveness and Economic Evaluation of HIV / AIDS-Related
Interventions: The State of the Art
Lilani Kumaranayake

Chapter 10: Randomized Trials of HIV Prevention Interventions in Developing
Countries
Marjorie Opuni, Stefano Bertozzi, Lia Fernald, Juan-Pablo Gutierrez, Lisa
DeMaria, Ken Morrison, Shanthi Noriega

Chapter 11: Economics of HIV/AIDS Impact Mitigation: Re-sponding to Problems
of Systemic Dysfunction and Sectoral Capacity
Ishrat Husain

Chapter 12: Antiretroviral Treatment for HIV-Infected Adults and Children in
Developing Countries: Some Evidence In Favor of Ex-panded Diffusion
J.P. Moatti, I. N�Doye, S.M. Hammer, P. Hale, M.D. Kazatchkine

Conclusion

�The success of the struggle against HIV/ AIDS will depend fundamentally on
effective national leadership in the most affected countries. Recent signs
of positive movement in that regard are encouraging. The recent and
unprecedented actions of governments of Africa to increase their commitment
to health care is one important step. The focus on HIV/AIDS within the
Poverty Reduction Strategy Papers being prepared by 22 governments in the
region to justify debt relief is another. International acceptance of the
emergency nature of the crisis has led virtually all pharmaceutical
companies to substantially reduce the barrier of high cost for
antiretrovirals. Acting individually and collectively, the world�s
high-income countries have also signalled that they recognize the need for
an extraordinary boost to the fight against AIDS.�

--Schwartlander, B et al. 2001. �Resource Needs for HIV/AIDS�. Science,
2434-2436.




--
To send a message to E-Drug, write to: e-drug@usa.healthnet.org
To subscribe or unsubscribe, write to: majordomo@usa.healthnet.org
in the body of the message type: subscribe e-drug OR unsubscribe e-drug
To contact a person, send a message to: e-drug-help@usa.healthnet.org
Information and archives: http://www.healthnet.org/programs/edrug.html